Faculty profile

Mohamed Elemary

Back to faculty

ProfessorHematological OncologyUniversity of Saskatchewan

Mohamed Elemary

Professor

Hematological Oncology

College of Medicine

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
16 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

929

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Cell Therapy Transplant Canada (CTTC) Consensus-Based Review for the Use of Supportive Care and Topical Therapies for Chronic Graft-Versus-Host Disease
Current Oncology · 2026
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium
Bone Marrow Transplantation · 2026
Grip strength is associated with overall survival in myelodysplastic syndrome.
Blood advances · 2026

All 33 publications

Latest funding

Platelet Transfusions in Hematopoietic Stem Cell Transplantation - The PATH Phase III Trial
CIHR · 2019 · Co-investigator
$1,507,050

All 1 grants and awards

33 publications.

Cell Therapy Transplant Canada (CTTC) Consensus-Based Review for the Use of Supportive Care and Topical Therapies for Chronic Graft-Versus-Host Disease

Lepic K, Aziz J, Popradi G, Lemieux C, White J, Maier S, Elemary M, Schultz K, Paulson K, Vasudevan Nampoothiri R

Current Oncology2026Open Access

DOI: 10.3390/curroncol33090548

A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium

Walker I, Deotare U, Elemary M, Elsawy M, Gallagher G, Kliman D, Panzarella T, Hamad N, Schultz KR, Storek J

Bone Marrow Transplantation2026Open Access

DOI: 10.1038/s41409-026-03024-7

Grip strength is associated with overall survival in myelodysplastic syndrome.

Chornenki NLJ, Mozessohn L, Chodirker L, Chow S, Kennedy JA, England JT, Cheung MC, Geddes M, Sabloff M, Christou G, Fulcher J, Rajendra A, St Hilaire E, Finn N, Zhu NY, Leber B, Garcia-Horton A, Trottier AM, Shamy A, Leitch HA, Houston BL, Landego I, Yee KWL, Nevill TJ, Storring J, Elemary M, Habib LA, Delage R, Siddiqui M, Zhang L, Buckstein RJ

Blood advances2026

DOI: 10.1182/bloodadvances.2026021036 PMID: 42782304

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Elemary Y, Sabry W, Stakiw J, Bosch M, Goubran H, Sanayei J, Kodad S, MacKay R, Lacey J, Sarker S, Elemary M

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2026Senior author

DOI: 10.1016/j.transci.2025.104304 PMID: 41443057

Improvement in quality of life in MDS patients who become transfusion independent after treatment

Wan BA, Alibhai SMH, Chodirker L, Mozessohn L, Geddes M, Zhu N, Trottier AM, St-Hilaire E, Finn N, Leber B

Leukemia and Lymphoma20255 citations

DOI: 10.1080/10428194.2024.2422844

Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.

Rodriguez-Rodriguez S, Desai N, Chen C, Jamani K, Sohier-Poirier C, Lemieux C, White J, Elemary M, Kennah M, Alfaro Moya T, Al-Shaibani E, Novitzky-Basso I, Pasic I, Law AD, Michelis FV, Viswabandya A, Kumar R, Mattsson J, Kim DDH

British journal of haematology20251 citationsOpen Access

DOI: 10.1111/bjh.70146 PMID: 40947302

Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Rodriguez-Rodriguez S, Desai N, Lemieux C, Vachon K, Jamani K, Elemary M, Alfaro-Moya T, Al-Shaibani E, Pasic I, Novitzky-Basso I, Michelis F, Viswabandya A, Kumar R, Mattsson J, Law A, Lachance S, Kim DDH

Annals of hematology20251 citationsOpen Access

DOI: 10.1007/s00277-025-06661-y PMID: 41136748

International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

Seth Joshua Rotz, Neel Sanjivbhai Bhatt, Betty K. Hamilton, Christine Duncan, Mahmoud Deeb Aljurf, Yoshiko Atsuta, Kristen L. Beebe, David Kyle Buchbinder, Peggy Burkhard, Paul A. Carpenter, Naeem Arshad Chaudhri, Mohamed Elemary, Mahmoud Elsawy, Gregory M.T. Guilcher, Nada Hamad, Amado Karduss, Zinaida Perić, Duncan Purtill, Douglas Rizzo, Morgani Rodrigues, Maria Belén Rosales Ostriz, Nina Salooja, Helene M. Schoemans, Adriana Seber, Akshay Sharma, Alok Srivastava, Susan K. Stewart, Kevin Scott Baker, Navneet S. Majhail, Rachel Phelan

Transplantation and Cellular Therapy202478 citationsOpen Access

DOI: 10.1016/j.jtct.2023.12.001 PMID: 38413247

International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

Bone Marrow Transplantation202417 citationsOpen Access

DOI: 10.1038/s41409-023-02190-2 PMID: 38413823

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Kim DDH, Popradi G, Lepic K, Paulson K, Allan D, Nampoothiri RV, Lachance S, Deotare U, White J, Elemary M

Current Oncology202413 citationsOpen Access

DOI: 10.3390/curroncol31030108 PMID: W4392584091

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Mohamed Elemary

Research

Latest papers

Latest funding

Cell Therapy Transplant Canada (CTTC) Consensus-Based Review for the Use of Supportive Care and Topical Therapies for Chronic Graft-Versus-Host Disease

Grip strength is associated with overall survival in myelodysplastic syndrome.

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Improvement in quality of life in MDS patients who become transfusion independent after treatment

Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.

Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Platelet Transfusions in Hematopoietic Stem Cell Transplantation - The PATH Phase III Trial

Frequent collaborators

Brian Leber

Waleed Sabry

Mitchell Sabloff

Irwin Ronald Walker

Rajat Kumar

Igor Novitzky-Basso

Mark Bosch

Jonas Mattsson

Lisa Chodirker

Kirk Schultz

Robert Delage

David Allan

Kristjan Paulson

Shabbir Alibhai

Tony Panzarella

Michael Kennah

Kylie Lepic

Jean Roy

John Kuruvilla

Lee Mozessohn

Tommy Alfaro Moya

Gregory Guilcher

Yayuan Zhao